0001179110-20-009648.txt : 20200909 0001179110-20-009648.hdr.sgml : 20200909 20200909205452 ACCESSION NUMBER: 0001179110-20-009648 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200904 FILED AS OF DATE: 20200909 DATE AS OF CHANGE: 20200909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Carl I. CENTRAL INDEX KEY: 0001573354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36790 FILM NUMBER: 201167554 MAIL ADDRESS: STREET 1: 20155 N.E. 38TH COURT, UNIT 3104 CITY: AVENTURA STATE: FL ZIP: 33180 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Predictive Oncology Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 BUSINESS PHONE: 651-389-4800 MAIL ADDRESS: STREET 1: 2915 COMMERS DRIVE, STREET 2: SUITE 900 CITY: EAGAN STATE: MN ZIP: 55121 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutics Inc. DATE OF NAME CHANGE: 20180314 FORMER COMPANY: FORMER CONFORMED NAME: Precision Therapeutic Inc. DATE OF NAME CHANGE: 20180208 FORMER COMPANY: FORMER CONFORMED NAME: Skyline Medical Inc. DATE OF NAME CHANGE: 20130807 4 1 edgar.xml FORM 4 - X0306 4 2020-09-04 0 0001446159 Predictive Oncology Inc. POAI 0001573354 Schwartz Carl I. 3750 LAS VEGAS BLVD. SOUTH APT. 4303 LAS VEGAS NV 89158 1 1 1 0 Chief Executive Officer Common Stock 1611981 D Stock Options (right to buy) 775.00 2020-09-04 4 D 0 52 0 D 2025-06-30 Common Stock 52 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 52 0 A 2025-06-30 Common Stock 52 52 D Stock Options (Right to buy) 28.00 2020-09-04 4 D 0 714 0 D 2026-12-31 Common Stock 714 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 714 0 A 2026-12-31 Common Stock 714 714 D Stock Options (Right to buy) 14.70 2020-09-04 4 D 0 37691 0 D 2027-06-22 Common Stock 37691 0 D Common Stock (Right to buy) 1.54 2020-09-04 4 A 0 37691 0 A 2027-06-22 Common Stock 37691 37691 D Stock Options (Right to buy) 14.70 2020-09-04 4 D 0 2834 0 D 2027-11-10 Common Stock 2834 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 2834 0 A 2027-11-10 Common Stock 2834 2834 D Stock Options (Right to buy) 9.70 2020-09-04 4 D 0 14178 0 D 2028-01-02 Common Stock 14178 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 14178 0 A 2028-01-02 Common Stock 14178 14178 D Stock Options (Right to buy) 11.30 2020-09-04 4 D 0 12168 0 D 2028-06-30 Common Stock 12168 0 D Common Stock (Right to buy) 1.54 2020-09-04 4 A 0 12168 0 A 2028-06-30 Common Stock 12168 12168 D Stock Options (Right to buy) 11.60 2020-09-04 4 D 0 4490 0 D 2028-08-01 Common Stock 4490 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 4490 0 A 2028-08-01 Common Stock 4490 4490 D Stock Options (Right to buy) 6.191 2020-09-04 4 D 0 32305 0 D 2029-01-02 Common Stock 32305 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 32305 0 A 2029-01-02 Common Stock 32305 32305 D Stock Options (Right to buy) 2812.50 2020-09-04 4 D 0 7 0 D 2023-07-19 Common Stock 7 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 7 0 A 2023-07-19 Common Stock 7 7 D Stock Options (Right to buy) 21.00 2020-09-04 4 D 0 238 0 D 2027-03-31 Common Stock 238 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 238 0 A 2027-03-31 Common Stock 238 238 D Stock Options (Right to buy) 28.00 2020-09-04 4 D 0 179 0 D 2026-12-31 Common Stock 179 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 179 0 A 2026-12-31 Common Stock 179 179 D Stock Options (Right to buy) 41.25 2020-09-04 4 D 0 121 0 D 2026-09-30 Common Stock 121 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 121 0 A 2026-09-30 Common Stock 121 121 D Stock Options (Right to buy) 37.50 2020-09-04 4 D 0 133 0 D 2026-06-30 Common Stock 133 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 133 0 A 2026-06-30 Common Stock 133 133 D Stock Options (Right to buy) 42.50 2020-09-04 4 D 0 59 0 D 2026-03-31 Common Stock 59 0 D Stock Options (Right to buy) 1.54 2020-09-04 4 A 0 59 0 A 2026-03-31 Common Stock 59 59 D All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020. Currently exercisable. Held by the Carl I. Schwartz Revocable Living Trust /s/ Carl I. Schwartz, DDS 2020-09-09